CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 120 enrolled
Drug / intervention
AcrySof Toric IOLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00760487
NCT00760487Phase 4Completed
CompareCT.gov

Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens

Alcon Research·interventional·Posted Sep 26, 2008·Updated Jan 16, 2012

In Brief

A Phase 4 clinical trial evaluating AcrySof Toric IOL for Cataract. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effect that placement and power of the AcrySof Toric has on post-operative visual acuity and spectacle independence for distance vision. This will be determined by comparing manifest refraction pre-operatively and post-operatively and by evaluating the rotational stability of the lens over time.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 26, 2008
Enrollment StartOct 1, 2006
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.8 years ago

Interventions

AcrySof Toric IOLdevice

Implantation with the AcrySof Toric IOL for cataract replacement and multiple follow-up assessments